Last update 21 Nov 2024

DCB-BO-1202

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Mechanism-
Therapeutic Areas
NeoplasmsInfectious DiseasesDigestive System Disorders+ [1]
Active Indication-
Inactive Indication
Fibrosis, LiverHepatitis B, ChronicHepatocellular Carcinoma+ [1]
Originator Organization
Goldenmed Biotechnology
Active Organization-
Inactive Organization
A2 Healthcare Taiwan Corp.Goldenmed BiotechnologyA2 Healthcare Corp.A2 Healthcare Corp.
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with DCB-BO-1202
NCT02289300 / WithdrawnPhase 2
A Phase II Randomized, Double-Blind, Placebo Controlled, Parallel Study of DCB-BO1202 for Alleviating Liver Fibrosis in HBV Patients With Intermediate Hepatocellular Carcinoma Receiving Loco-regional Therapies
100 Clinical Results associated with DCB-BO-1202
Login to view more data
100 Translational Medicine associated with DCB-BO-1202
Login to view more data
100 Patents (Medical) associated with DCB-BO-1202
Login to view more data
100 Deals associated with DCB-BO-1202
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Fibrosis, LiverPhase 2
TW
A2 Healthcare Taiwan Corp.
01 Jan 2020
Fibrosis, LiverPhase 2
TW
Goldenmed Biotechnology
01 Jan 2020
Hepatitis B, ChronicPhase 2
TW
A2 Healthcare Taiwan Corp.
01 Jan 2020
Hepatitis B, ChronicPhase 2
TW
Goldenmed Biotechnology
01 Jan 2020
Hepatocellular CarcinomaPhase 2
TW
Goldenmed Biotechnology
01 Jan 2020
Hepatocellular CarcinomaPhase 2
TW
A2 Healthcare Taiwan Corp.
01 Jan 2020
Liver CirrhosisPhase 2-
Goldenmed Biotechnology
-
Liver CirrhosisPhase 2-
A2 Healthcare Corp.A2 Healthcare Corp.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free